Gastrointestinal Cancers

Surgical palliation improved quality of live and solid food intake in patients with certain types of gastric cancer, according to a recent study.

A recent study found that Opdivo improves survival in patients with gastric or gastroesophageal junction (GEJ) cancer.

The JAVELIN trial showed that many patients with gastric cancer could benefit from immunotherapy.

Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.

Since chemotherapy can offer only a limited amount of help in fighting gastroesophageal cancers, a growing emphasis on prevention — as well as on the development of immunotherapies — will be extremely important.

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.

Diagnoses in younger people and two causative infections are providing clues about how to better prevent and treat gastric cancer.

The decision to remove one's stomach may be difficult, but it can also be life-saving.

Results from new clinical trials signal a role for the immunotherapy Opdivo in the treatment of gastric cancer and heavily pretreated esophageal cancer.

I will be out on the street in New York City on November 1 to cheer on James Blake.

Moving back into the light.

The medical team had reached some conclusions.

This is how I became hospital property.

Twenty strokes signaled that there was trouble, though no one would have suspected a tumor.

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

It is now well recognized that the presence of a molecular abnormality shown to be actionable in one tumor type may be highly clinically relevant in other malignancies.

In the hopes of recreating the successes achieved in other solid malignancies, researchers have evaluated many types of targeted therapy for the treatment of advanced gastric cancer.

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.

Debbie Zelman is the founder and president of Debbie's Dream Foundation: Curing Stomach Cancer, a nonprofit organization that is dedicated to educating and supporting patients and their families.

Among patients with metastatic gastric cancer treated with the PD-1 inhibitor Keytruda, the agent showed promising activity, according to updated findings from the KEYNOTE-012 study presented at the Gastrointestinal Cancers Symposium.

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

Why is November not named an "awareness month?" Because stomach cancer isn't only about awareness.

The FDA approves Cyramza (ramucirumab) in combination with paclitaxel for the treatment of advanced gastric cancer or GEJ adenocarcinoma.

Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.